Filetype
LUCC has 17 strategic translational networks based on cancer diagnosis, technology or processes. The aim of the networks is to bridge the basic and clinical science and the diverse disciplines. Networking activities include discussions about scientific challenges in the field, facilitation of new collaborations, and sharing technical and educational expertise. The key goal is to create opportuniti
https://www.lucc.lu.se/internal/research/strategic-networks - 2026-05-15
Breast cancer is the most common diagnosis among women worldwide, and the LUCC-Breast network is the largest cancer research area at Lund University. LUCC-Breast comprises over 20 groups and 150 members in Lund and Malmö. The scientific focus areas span from basic science to clinical studies, with major research projects within genomics, genetics, tumor biology, cell signaling, prognostic and pred
https://www.lucc.lu.se/internal/research/strategic-networks/lucc-breast-network - 2026-05-15
The UroCAN - LUCC center aims to develop healthcare and research with a focus on the three most common forms of urological cancer: prostate cancer, bladder cancer and kidney cancer. To goal of the network is to facilitate the collaboration between clinics, research, business and patient representatives to face current paradigm shifts with molecular diagnostics and new treatments. The aim of the ce
https://www.lucc.lu.se/internal/research/strategic-networks/urocan-lucc - 2026-05-15
Pediatric oncology focuses on diagnosing and treating cancer in children and adolescents, presenting unique challenges due to the rarity and diverse nature of childhood cancers. In Sweden, approximately 350 children are diagnosed with cancer yearly, whereas 55 000-60 000 adults receive a cancer diagnosis. Among these 350 children, a large diversity of cancers are seen, ranging from leukemia and br
https://www.lucc.lu.se/internal/research/strategic-networks/child-cancer-network - 2026-05-15
Cancer epidemiology is broadly about studying the distribution, patterns, and causes of cancer and cancer progression in a population. The population investigated can be small or large, ranging from hundreds to millions of individuals, either population-based or a selected population such as a particular risk group for cancer or cancer patients. Many designs can be used in cancer epidemiology. The
https://www.lucc.lu.se/internal/research/strategic-networks/cancer-epidemiology - 2026-05-15
Gastrointestinal network consists of two sub-networks with focus on two different aspects of gastrointestinal cancer: - Colorectal network (Milladur Rahman & Marie-Louise Lydrup) - Hepatic-Pancreatic-Biliary (HPB) network (Monika Bauden & Daniel Ansari) Colorectal cancer is the third most common malignancy. Despite improvements in recent decades the 5-year survival is 65%. Tumour recurrence is com
https://www.lucc.lu.se/internal/research/strategic-networks/gastrointestinal-network - 2026-05-15
The network research issues related to nursing, rehabilitation, and palliative care in the context of cancer. Most of the research is conducted in close connection and collaboration with the clinical practice within the southern healthcare region as well as in national and international collaboration and focuses on areas e.g., early integrated palliative care, palliative eHealth, symptom managemen
https://www.lucc.lu.se/internal/research/strategic-networks/nursing-rehabilitation-and-palliative-care - 2026-05-15
Clinical Trials in Cancer (online)organised by roger [dot] olofsson [dot] bagge [at] gu [dot] se (Roger Olofsson Bagge), UGOTAvailable through September 2026 - May 2027The course provides an understanding of the regulatory and quality principles that govern clinical trials for drugs, biomarkers and medical devices, including Good Clinical Practice (GCP), and different types of study design. The co
https://www.lucc.lu.se/internal/CARES/cares-courses - 2026-05-15
The vision of LUCC imaging is to serve as a cutting-edge hub that integrates advanced technologies, fosters interdisciplinary collaboration, and facilitates groundbreaking discoveries to advance our understanding of biological processes, diseases, and therapeutic interventions. Imaging plays a pivotal role in both preclinical and clinical research, offering benefits that significantly impact disea
https://www.lucc.lu.se/internal/research/strategic-networks/imaging - 2026-05-15
Bone and soft tissue tumors are very frequent. Less than 1% of them, however, are malignant, so-called sarcomas. Among these sarcomas, more than 50 different subtypes have been discerned, each individually rare and with its own biological and clinical features. Despite numerous breakthroughs in the last few decades, the proportion (around 1/3) who cannot be cured remains too high. Thus, better app
https://www.lucc.lu.se/internal/research/strategic-networks/sarcoma-network - 2026-05-15
Tumors of the brain, spinal cord and the pituitary comprise about one hundred different entities. The most common, and also the most aggressive, brain tumor in adults is glioblastoma. Patients suffering glioblastoma have a short median overall survival time despite extensive surgical resection and adjuvant chemo- and radiotherapy. Tumor recurrence almost invariably occurs and poses one of the most
https://www.lucc.lu.se/internal/lucc-brain - 2026-05-15
Skin cancer is the most common malignancy and includes the main forms basal cell carcinoma, squamous cell carcinoma and malignant melanoma. The most aggressive type, malignant melanoma, affects more than 5000 individuals each year in Sweden and the incidence is still increasing. The treatment for advanced stage melanoma has dramatically changed during the last decade with clinical introduction of
https://www.lucc.lu.se/internal/research/strategic-networks/skin - 2026-05-15
Lung cancer is the malignancy responsible for most cancer related deaths. It affects close to 4000 individuals each year in Sweden and is strongly associated with specific risk factors, in particular smoking. At the molecular level, lung cancer is a highly heterogeneous disease. The treatment for lung cancer has dramatically changed during the last decades with clinical introduction of targeted th
https://www.lucc.lu.se/internal/research/strategic-networks/lung-network - 2026-05-15
Blood cancer is a type of malignancy that affects the hematopoietic (= blood cell forming) system. Leukemia, lymphoma and myeloma are some of the most common types of blood cancer which arise from the blood forming bone marrow including the lymphatic system. In Sweden about 4500 new cases of blood cancer are diagnosed every year. The LUCC-Blood network is one of the largest cancer research areas a
https://www.lucc.lu.se/internal/research/strategic-networks/blood-lymphoma-myeloma - 2026-05-15
Head and neck cancer (HNC) is the 6th most incident cancer worldwide: in Sweden approx. 1,600 patients per year present with the disease. It involves malignancies localised to the sinonasal and oral cavities, the pharynx, the larynx, and the salivary glands. Conventionally, treatments include surgery and radio¬therapy (w/wo chemotherapy). The recent introduction of immunotherapy, notably immune ch
https://www.lucc.lu.se/internal/research/strategic-networks/head-and-neck-network - 2026-05-15
- Nurture: Training both current and the next generation of cancer researchers LUCC actively contributes to an effective and coherent education in current curricula with relevance for cancer with a clear progression between all levels from basic education to postgraduate education and clinical specialist training. In addition, continued training and education for personnel affiliated to LUCC will
https://www.lucc.lu.se/internal/education - 2026-05-15
The LUCC gynecological cancer network encompasses all researchers with an interest in gynecological cancer, including ovarian, cervical and endometrial cancer. The network activities aim to bring together researchers from all disciplines, to promote collaboration and exchange of ideas and methodological knowledge. Research within the network spans the whole spectrum of cancer research, from basic
https://www.lucc.lu.se/internal/research/strategic-networks/gynaecology - 2026-05-15
A new updated CARES was launched during 2022 with new content and courses. Among our CARES Alumni you will find both clinical and pre-clinical cancer researchers. Cancer Research South (CARES) School is a graduate research school for clinical and pre-clinical PhD students in cancer research. The research school is a collaboration between Lund University (LU) and University of Gothenburg (UGOT) und
https://www.lucc.lu.se/internal/CARES - 2026-05-15
The vision of LUCC Cancer prevention is to serve as a hub that fosters interdisciplinary collaboration, facilitates discoveries to advance our understanding of underlying cancer risk and prognostic factors, socioecological phenomena, environmental factors, biological processes, screening programs, health promoting programs and therapeutic interventions in order to promote Cancer prevention at diff
https://www.lucc.lu.se/internal/research/strategic-networks/cancer-prevention - 2026-05-15
19 May 2026 09:00 to 17:00 | Conference LUCC Research Day - Internal meeting 19 May 2026; full day; Auditorium, Inspira building Medicon VillageWe are delighted to invite you to register for the LUCC Research Day 2026. Details are as follows:Date: Tuesday, May 19th, 2026Time: 9:00 AM – 5:00 PM (followed by a dinner)Venue: Main Auditorium, Building Inspira, Medicon Village, Scheeletorget 1, Lundhtt
https://www.lucc.lu.se/internal/calendar/lucc-internal-meeting-lucc-research-day - 2026-05-15
